Diphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine(Yuxi Walvax biotechnology))
吸附无细胞百白破/b型流感嗜血杆菌联合疫苗（玉溪沃森生物）
Report date: 2025/07/15 20:00:07
Base Information
Drug NameDiphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine(Yuxi Walvax biotechnology))
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesYuxi Walvax Biotechnology Co LtdWalvax Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesWalvax Biotechnology Co LtdYuxi Walvax Biotechnology Co Ltd
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A